|

Psychedelic Spotlight Interview With Ronan Levy

ByJill Ettinger
Microdosing Psychedelics Recent Rediscovery

Global Trac Solutions, Inc. CEO, David Flores and Field Trip Health, Inc. Founder and Executive Chairman, Ronan Levy discuss psychedelic-assisted psychotherapy and emerging space of psychedelic medicine.

Jill Ettinger is the co-founder and global editorial director for sustainable luxury and wellness platform, Ethos.

Similar Posts

  • Interview with James Lanthier, CEO of Mindset Pharma

    Interviews, Listen, Podcasts

    In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.

  • MindMed 2021 Year-End Conference Call and Earnings: Big Updates for MNMD Stock

    Listen, Videos

    MindMed 2021 Year-End Conference Call and Earnings: Big Updates for MNMD Stock

    Join our Newsletter (scroll to the bottom of the page and sign up): https://psychedelicspotlight.com/psychedelic-news/industry/

    All Psychedelic Stock investors should take the time to listen to the conference calls of the companies they are investing in. That is doubly important for year-end calls, as often information is divulged on the direction of the company. If you are invested in MNMD or MMED stock, you need to listen to this call.

    Follow us on Twitter:
    The Psychedelic Investor: @psycInvestor
    James: @Psy_Invest
    Maria: @psy_holy
    Psychedelic Spotlight: @PsycSpotlight

    Follow us on Instagram:
    @thepsychedelicinvestor
    @psycspotlight

    To learn more about the emerging psychedelic industry, visit:
    https://psychedelicspotlight.com/

    Meet Kevin O’Leary, Rober Barrow, Daniel Carcillo and other psychedelic leaders @ the Benzinga Psychedelics Capital Conference.on April 19 @ Fontainebleau Hotel, Miami!
    https://www.eventbrite.com/e/benzinga-psychedelics-capital-conference-spring-2022-tickets-238697028237?discount=PSYCHSPOTLIGHT15&fbclid=IwAR3tJFhoVfVWZvAyQuWSLEo3kJSmaq8VGnQQPz04NMhG3g7rHtSmRSAUq64

    COUPON CODE: PSYCHSPOTLIGHT15

    Interested in going to Malta for Plant Medicine Week April 5th-8th? Get discounted tickets here: https://tickets.plantmedicineweek.com/attendance/event/index/41436/EN?promocodes=PSYC

    In this MindMed 2021 conference and earnings call, we gained important insights into the company’s many projects. These include: Project Lucy, which attempts to treat Anxiety using LSD; Project Angie, attempting to treat pain with LSD; Project Layla, attempting to treat addiction with 18-MC, and much more.

    The company gives some updates on the science of psychedelics, as well as their hiring strategy and financial updates. MindMed is a company working on treating mental health conditions with psychedelics. They are a leading player in the shroom boom, and they aim to commercialize psychedelics as medicines.

    Some of the questions MindMed is trying to answer are:

    Can Psychedelics treat Mental Health conditions?

    Can Psychedelics treat depression?

    Can Psychedelics treat anxiety?

    Can Psychedelics treat ADHD?

    Can Psychedelics help with Autism?

    Can Psychedelics help treat pain?

    #MindMed #MNMD #MindMedStocks

  • Interview With Dr. Steven Mandel

    Listen, Podcasts

    In this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking with one of the foremost experts in ketamine-assisted therapy, Dr. Steven L. Mandel, Founder and President of Ketamine Clinics Los Angeles.